ARHCF(ARHCF)
ARHCF
No analyst ratings available
No analyst price targets available for ARHCF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $3.24T | $3.32T | $3.39T | $3.47T | $3.55T |
| Low | $3.23T | $3.29T | $3.37T | $3.45T | $3.53T |
| High | $3.26T | $3.34T | $3.41T | $3.49T | $3.57T |
| EBITDA Avg | $63.50B | $64.97B | $66.34B | $67.92B | $69.56B |
| Low | $63.15B | $64.45B | $65.89B | $67.46B | $69.09B |
| High | $63.81B | $65.31B | $66.68B | $68.27B | $69.92B |
| EBIT Avg | $47.60B | $48.70B | $49.73B | $50.91B | $52.14B |
| Low | $47.34B | $48.31B | $49.39B | $50.57B | $51.79B |
| High | $47.83B | $48.95B | $49.98B | $51.17B | $52.41B |
| Net Income Avg | $24.18B | $26.10B | $27.77B | $29.35B | $31.01B |
| Low | $23.97B | $25.87B | $27.53B | $29.10B | $30.74B |
| High | $24.34B | $26.27B | $27.96B | $29.55B | $31.21B |
| EPS Avg | $133.01 | $143.57 | $152.78 | $161.48 | $170.58 |
| Low | $131.85 | $142.32 | $151.45 | $160.07 | $169.09 |
| High | $133.89 | $144.52 | $153.79 | $162.55 | $171.71 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $796.81B | $869.01B | $782.66B |
| Low | $789.62B | $863.60B | $776.73B |
| High | $804.00B | $874.43B | $788.58B |
| EBITDA Avg | $15.60B | $17.01B | $15.32B |
| Low | $15.46B | $16.90B | $15.20B |
| High | $15.74B | $17.12B | $15.44B |
| EBIT Avg | $11.69B | $12.75B | $11.48B |
| Low | $11.58B | $12.67B | $11.40B |
| High | $11.80B | $12.83B | $11.57B |
| Net Income Avg | $5.43B | $20.35B | $4.65B |
| Low | $5.38B | $20.15B | $4.61B |
| High | $5.49B | $20.55B | $4.70B |
| EPS Avg | $30.38 | $113.81 | $26.02 |
| Low | $30.08 | $112.69 | $25.76 |
| High | $30.68 | $114.93 | $26.27 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |